Download PDF
Synlett 2011(19): 2841-2843  
DOI: 10.1055/s-0031-1289564
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

A Short Synthesis of a Trifold Orthogonally Protected, Novel Aminoazepanol Building Block

Martina Würdemann, Jens Christoffers*
Institut für Reine und Angewandte Chemie, Carl von Ossietzky Universität Oldenburg, 26111 Oldenburg, Germany
Fax: +49(441)7983873; e-Mail: jens.christoffers@uni-oldenburg.de;
Further Information

Publication History

Received 25 August 2011
Publication Date:
31 October 2011 (online)

    Permissions and Reprints All articles of this category

Abstract

Orthogonally protected cis-5-aminoazepan-3-ol derivatives were prepared in three steps from N-Boc allylic amine, acrolein, and N-benzylhydroxylamine with an intramolecular 1,3-dipolar cycloaddition as the key reaction.

Key words

azepanes - amines - 1,3-dipolar cycloaddition - N-heterocycles - nitrones

    References and Notes

  • 1a Horbal JM. Bernstein JA. Clin. Med. Insights Therapeut.  2010,  2:  427 
  • 1b Bernstein JA. Curr. Med. Res. Opin.  2007,  23:  2441 
  • 2 Tolle N. Kunick C. Curr. Top. Med. Chem.  2011,  11:  1320 
    Google Scholar
  • 3 Gallo C. Renzi P. Loizzo S. Loizzo A. Capasso A. Pharmacologyonline  2009,  3:  906 
    Google Scholar
  • 4 Delmore RJ. Hodgen JM. Johnson BJ. J. Anim. Sci.  2010,  88:  2825 
    Google Scholar
  • 5a Marcelo F. He Y. Yuzwa SA. Nieto L. Jimenez-Barbero J. Sollogoub M. Vocadlo DJ. Davies GD. Bleriot Y. J. Am. Chem. Soc.  2009,  131:  5390 
  • 5b Li H. Marcelo F. Bello C. Vogel P. Butters TD. Rauter AP. Zhang Y. Sollogoub M. Bleriot Y. Bioorg. Med. Chem.  2009,  17:  5598 
  • 5c Li H. Bleriot Y. Mallet J.-M. Rodriguez-Garcia E. Vogel P. Zhang Y. Sinay P. Tetrahedron: Asymmetry  2005,  16:  313 
  • 5d Winkler DA. J. Med. Chem.  1996,  39:  4332 
  • 5e Farr RA. Holland AK. Huber EW. Peet NP. Weintraub PM. Tetrahedron  1994,  50:  1033 
  • 6 Tanaka K.-i. Nemoto H. Sawanishi H. Tetrahedron: Asymmetry  2005,  16:  1989 
    Google Scholar
  • 7a Schramm H. Saak W. Hoenke C. Christoffers J. Eur. J. Org. Chem.  2010,  1745 
  • 7b Rosiak A. Hoenke C. Christoffers J. Eur. J. Org. Chem.  2007,  4376 
  • 8 De Amici M. De Micheli C. Misani V. Tetrahedron  1990,  46:  1975 
    Google Scholar
  • 9 Humphrey JM. Liao Y. Ali A. Rein T. Wong Y.-L. Chen H.-J. Courtney AK. Martin SF. J. Am. Chem. Soc.  2002,  124:  8584 
    Google Scholar
  • 11 Maskill H. Jencks WP. J. Am. Chem. Soc.  1987,  109:  2062 
    Google Scholar
  • 12 Confalone PN. Huie EM. Org. React.  1988,  36:  1 
    Google Scholar
  • 13a LeBel NA. Post ME. Whang JJ. J. Am. Chem. Soc.  1964,  86:  3759 
  • 13b Oppolzer W. Keller K. Tetrahedron Lett.  1970,  1117 
10

tert -Butyl N -Allyl- N -(3-oxopropyl)carbamate (6) Acrolein (16.9 g, 302 mmol) and camphorsulfonic acid (1.40 g, 6.04 mmol) were added to an ice-cooled solution of N-Boc allylamine (5, 4.75 g, 30.2 mmol) in CH2Cl2 (75 mL). The resulting solution was stirred at 0 ˚C for 15 min and at 23 ˚C for 30 min. The mixture was then washed with sat. NaHCO3 solution (75 mL), and the organic layer was dried (MgSO4). After filtration, the solvent was removed, and the residue was purified by chromatography on SiO2 (hexane-MTBE, 1:1; R f  = 0.33) to yield the title compound 6 (4.34 g, 20.4 mmol, 67%) as a colorless liquid. ¹H NMR (500 MHz, CDCl3): δ = 1.42 (s, 9 H), 2.61-2.69 (m, 2 H), 3.45-3.53 (m, 2 H), 3.76-3.85 (m, 2 H), 5.05-5.15 (m, 2 H), 5.67-5.80 (m, 1 H), 9.76 (t, J = 1.6 Hz, 1 H) ppm. ¹³C{¹H} NMR (125 MHz, CDCl3): δ = 28.29 (3 × CH3), 40.64 (CH2), 43.34 (CH2), 50.42 (CH2), 79.97 (C), 116.36 (CH2), 133.95 (CH), 155.16 (C), 200.85 (CH) ppm. IR (ATR): 3084 (w), 2976 (w), 2932 (w), 2725 (w), 1723 (m), 1687 (vs), 1463 (m), 1407 (s), 1366 (s), 1247 (s), 1168 (vs), 1145 (vs), 920 (m), 864 (m), 774 (m) cm-¹. MS (CI, isobutane): m/z (%) = 214 (49) [M + H+], 158 (100). HRMS: m/z calcd for C11H20NO3: 214.1443; found: 214.1437 [M + H+]; C11H19NO3 (213.27).

14

tert -Butyl 7-Benzyl-8-oxa-3,7-diazabicyclo[4.2.1]nonane-3-carboxylate (9) Benzylhydroxylamine (485 mg, 3.94 mmol) was added to a solution of aldehyde 6 (800 mg, 3.75 mmol) in MeCN (16 mL), and the mixture was stirred for 30 min at 23 ˚C and for 16 h under reflux. The solvent was evaporated, and the residue was chromatographed on SiO2 (hexane-EtOAc, 2:1; R f  = 0.29) to yield the title compound 9 (964 mg, 3.03 mmol, 81%) as a colorless solid, mp 65-66 ˚C. Due to the carbamate group, NMR spectra show a partially doubled signal set. ¹H NMR (500 MHz, CDCl3): δ = 1.47 (s, 9 H), 1.55-1.70 (m, 2 H, 5-H), 1.83-1.89 (m, 1 H, 9-H), 2.49-2.57 (m, 1 H, 9-H), 2.94 (d, J = 14.6 Hz, 1/2 H, 2-H), 3.04 (d, J = 14.7 Hz, 1/2 H, 2-H), 3.08-3.15 (m, 1/2 H, 4-H), 3.15-3.23 (m, 1/2 H, 4-H), 3.43-3.47 (m, 1 H, 6-H), 3.73 (d, J = 12.8 Hz, 1/2 H, BnCH2), 3.75 (d, J = 12.6 Hz, 1/2 H, BnCH2), 3.77-3.83 (m, 1/2 H, 4-H), 3.83-3.86 (m, 1/2 H, 2-H), 3.94-3.99 (m, 1/2 H, 4-H), 4.01-4.07 (m, 1/2 H, 2-H), 4.06 (d, J = 12.7 Hz, 1 H, BnCH2), 4.69 (dd, J = 8.8, 3.4 Hz, 1/2 H, 1-H), 4.72 (dd, J = 8.7, 3.6 Hz, 1/2 H, 1-H), 7.25-7.30 (m, 1 H), 7.31-7.39 (m, 4 H) ppm. ¹³C{¹H} NMR (125 MHz, CDCl3): δ = 28.27 (3 × CH3), 32.10 (1/2 CH2, C-9), 32.23 (1/2 CH2, C-9), 32.95 (1/2 CH2, C-5), 33.57 (1/2 CH2, C-5), 42.00 (1/2 CH2, C-4), 42.58 (1/2 CH2, C-4), 49.72 (1/2 CH2, C-2), 50.79 (1/2 CH2, C-2), 60.35 (1/2 CH, C-6), 60.48 (1/2 CH, C-6), 62.77 (CH2, Ph-CH2), 77.52 (1/2 CH, C-1), 77.70 (1/2 CH, C-1), 79.24 (1/2 C, BocC), 79.41 (1/2 C, BocC), 127.24 (CH), 128.27 (2 × CH), 128.80 (CH), 128.86 (CH), 137.37 (C), 154.87 (1/2 C), 155.48 (1/2 C) ppm. IR (ATR): 2975 (m), 2952 (m), 2910 (m), 1688 (vs), 1461 (s), 1413 (vs), 1364 (s), 1322 (s), 1172 (vs), 1125 (vs), 1063 (s), 984 (s), 878 (vs), 810 (m), 744 (vs), 698 (s) cm-¹. MS (CI, isobutane): m/z (%) = 319 (100) [M + H+], 263 (16). HRMS: m/z calcd for C18H27N2O3: 319.2022; found: 319.2015 [M + H+]; C18H26N2O3 (318.41).

15

cis -5-(Benzyloxycarbonylamino)-1-( tert -butyloxy-carbonyl)-3-hydroxyazepane (10) Pd/C (100 mg, 10% w/w Pd) and ammonium formate (315 mg, 5.00 mmol) were added to a solution of isoxazolidine 9 (318 mg, 1.00 mmol) in MeOH (8 mL), and the mixture was heated under reflux for 3 h. After cooling, the mixture was filtered through Celite, the residue was rinsed with CH2Cl2 (ca. 15 mL), and the filtrate was evaporated. The residue was dissolved in MeOH (3 mL) and the solution cooled in an ice bath. CbzCl (239 mg, 1.40 mmol) and Et3N (142 mg, 1.40 mmol) were added, the ice bath was removed, and the mixture stirred at 23 ˚C for 16 h. After removing the solvents under reduced pressure the residue was purified by chromatography on SiO2 (hexane-MTBE, 10: 1; R f  = 0.27) to give the title compound 10 (240 mg, 0.659 mmol, 66%) as a colorless resin. Due to the carbamate group, NMR spectra show a partially doubled signal set, ratio ca. 2:1. ¹H NMR (500 MHz, CDCl3): δ = 1.42 (s, 18/3 H), 1.46 (s, 9/3 H), 1.74-1.85 (m, 2 H), 1.87-1.96 (m, 1 H), 2.01-2.10 (m, 1 H), 3.14 (dt, J = 14.1, 5.6 Hz, 1 H), 3.23 (dd, J = 15.0, 2.7 Hz, 1 H), 3.28-3.41 (m, 1 H), 3.49-3.61 (m, 2/3 H), 3.64-3.71 (m, 2/3 H), 3.74-3.80 (m, 1/3 H), 3.84 (dd, J = 14.9, 4.6 Hz, 2/3 H), 3.88-3.94 (m, 2/3 H), 4.02-4.09 (m, 1/3 H), 4.11-4.17 (m, 2/3 H), 5.08 (s, 2 H), 5.55 (d, J = 7.2 Hz, 1/3 H), 5.88 (d, J = 6.7 Hz, 2/3 H), 7.28-7.33 (m, 1 H), 7.33-7.37 (m, 4 H) ppm. ¹³C{¹H} NMR (125 MHz, CDCl3): δ = 28.17 (6/3 CH3), 28.31 (3/3 CH3), 32.37 (1/2 CH2), 33.62 (1/2 CH2), 40.26 (1/2 CH2), 41.76 (1/2 CH2), 43.64 (1/2 CH2), 43.93 (1/2 CH2), 47.90 (CH), 50.17 (1/2 CH2), 52.63 (1/2 CH2), 66.36 (1/2 CH2), 66.68 (1/2 CH2), 68.78 (1/2 CH), 69.96 (1/2 CH), 80.11 (1/2 C), 80.32 (1/2 C), 127.93 (2 CH), 128.02 (CH), 128.34 (2 ¥ CH), 136.45 (C), 154.98 (1/2 C), 155.53 (1/2 C), 157.49 (C) ppm. IR (ATR): 3324 (m), 3065 (w), 3034 (w), 2975 (m), 2930 (m), 1689 (vs), 1668 (vs),1527 (m), 1479 (m), 1454 (m), 1416 (s), 1366 (s), 1248 (s), 1160 (vs),
1058 (s), 1027 (s), 865 (m), 736 (s), 697 (s) cm-¹. MS (CI, isobutane): m/z (%) = 365 (28) [M + H+], 309 (100). HRMS: m/z calcd for C19H29N2O5: 365.2077; found: 365.2068 [M + H+]; C19H28N2O5 (364.44).

16

cis -3-Acetoxy-5-(benzyloxycarbonylamino)-1-( tert -butyl-oxycarbonyl)azepane (12)
Pyridine (316 mg, 3.99 mmol) and Ac2O (407 mg, 3.99 mmol) were added to a solution of azepanol 10 (969 mg, 2.66 mmol) in CH2Cl2 (10 mL). The solution was stirred at 23 ˚C for 24 h, and then the solvent was removed in vacuum. The residue was chromatographed on SiO2 (hexane-MTBE, 1:2; R f  = 0.26) to yield ester 12 as a colorless oil (960 mg, 2.36 mmol, 89%). Due to the carbamate groups NMR spectra show a partially doubled signal set. ¹H NMR (500 MHz, CDCl3): δ = 1.45 (s, 1/2 × 9 H), 1.47 (s, 1/2 × 9 H), 1.74-1.94 (m, 2 H), 1.96-2.01 (m, 1 H), 2.02 (s, 1/2 × 3 H), 2.05 (s, 1/2 × 3 H), 2.07-2.12 (m, 1 H), 3.14-3.26 (m, 1 H), 3.38-3.46 (m, 1/2 H), 3.50-3.66 (m, 2 H), 3.72-3.85 (m, 1 H), 3.88-3.96 (m, 1/2 H), 5.00-5.15 (m, 7/2 H), 5.22 (d, J = 7.4 Hz, 1/2 H), 7.30-7.39 (m, 5 H) ppm. ¹³C{¹H} NMR (125 MHz, CDCl3): δ = 21.06 (CH3), 28.23 (3 CH3), 33.25 (1/2 CH2), 33.94 (1/2 CH2), 38.28 (1/2 CH2), 38.77 (1/2 CH2), 43.58 (1/2 CH2), 44.12 (1/2 CH2), 47.62 (1/2 CH), 47.93 (1/2 CH), 49.94 (CH2), 66.51 (CH2), 70.51 (CH), 79.81 (1/2 C), 79.98 (1/2 C), 127.97 (2 CH), 128.02 (CH), 128.40 (2 CH), 136.35 (C), 155.04 (C), 155.27 (C), 169.67 (C) ppm. IR (ATR): 3327 (w), 2975 (w), 2936 (w), 1690 (vs), 1525 (m), 1455 (m), 1415 (m), 1366 (m), 1231 (vs), 1157 (s), 1030 (s), 699 (m), 646 (m), 624 (m) cm-¹. MS (CI, isobutane): m/z (%) = 407 (16) [M + H+], 351 (100), 307 (17). HRMS: m/z calcd for C21H31N2O6: 407.2182; found: 407.2180 [M + H+]; C21H30N2O6 (406.47).